Adjuvant Chemoradiotherapy After Pancreatic Resection for Invasive Carcinoma Associated With Intraductal Papillary Mucinous Neoplasm of the Pancreas

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 839-844

  Swartz, Michael J ^a   Hsu, Charles C ^a   Pawlik, Timothy M ^a   Winter, Jordan ^a   Hruban, Ralph H ^a   Guler, Mehmet ^a   Schulick, Richard D ^a   Cameron, John L ^a   Laheru, Daniel A ^a   Wolfgang, Christopher L ^a   Herman, Joseph M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

adjuvant therapy; intraductal papillary mucinous neoplasm; invasive carcinoma; Pancreatic adenocarcinoma; radiotherapy

Indexed keywords

ADJUVANT THERAPY; CHEMORADIOTHERAPY; CONFIDENCE INTERVAL; HOPKINS; INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM; LYMPH NODE; LYMPH NODE METASTASIS; MEDIAN SURVIVAL; MULTI VARIATE ANALYSIS; PANCREATIC ADENOCARCINOMA; PERINEURAL INVASION; POSITIVE SURGICAL MARGIN; RELATIVE RISKS; SURVIVAL RATE; TUMOR SIZE;

BODY FLUIDS; DECISION MAKING; FLUORESCENT SCREENS; MULTIVARIANT ANALYSIS; PATHOLOGY; RADIOTHERAPY; SURGERY; TUMORS;

FISH;

FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTINUOUS INFUSION; FEMALE; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 76049088876     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.071     Document Type: Article

References (18)

1. Hruban R.H., Takaori K., Klimstra D.S., et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28 (2004) 977-987
2. Azar C., Van de Stadt J., Rickaert F., et al. Intraductal papillary mucinous tumours of the pancreas: Clinical and therapeutic issues in 32 patients. Gut 39 (1996) 457-464
3. Brune K., Abe T., Canto M., et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 30 (2006) 1067-1076
4. Hruban R.H., Petersen G.M., Ha P.K., et al. Genetics of pancreatic cancer: From genes to families. Surg Oncol Clin North Am 7 (1998) 1-23
5. Iacobuzio-Donahue C.A., Klimstra D.S., Adsay N.V., et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: Comparison with conventional ductal adenocarcinomas. Am J Pathol 157 (2000) 755-761
6. Adsay N.V., Merati K., Andea A., et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: Differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 15 (2002) 1087-1095
7. Sasaki S., Yamamoto H., Kaneto H., et al. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas. Oncol Rep 10 (2003) 21-25
8. Kalser M.H., and Ellenberg S.S. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120 (1985) 899-903
9. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
10. Herman J.M., Swartz M.J., Hsu C.C., et al. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 26 (2008) 3503-3510
11. Regine W.F., Winter K.A., Abrams R.A., et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial. JAMA 299 (2008) 1019-1026
12. Nakagohri T., Asano T., Kenmochi T., et al. Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas. World J Surg 26 (2002) 1166-1169
13. Salvia R., Fernandez-del Castillo C., Bassi C., et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: Clinical predictors of malignancy and long-term survival following resection. Ann Surg 239 678 (2004) 685-687
14. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221 721 (1995) 731-733
15. Sohn T.A., Yeo C.J., Cameron J.L., et al. Intraductal papillary mucinous neoplasms of the pancreas: An updated experience. Ann Surg 239 788 (2004) 797-799
16. Corsini M.M., Miller R.C., Haddock M.G., et al. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: The Mayo Clinic experience (1975-2005). J Clin Oncol 26 (2008) 3511-3516
17. Oettle H., and Neuhaus P. Adjuvant therapy in pancreatic cancer: A critical appraisal. Drugs 67 (2007) 2293-2310
18. Chari S.T., Yadav D., Smyrk T.C., et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 123 (2002) 1500-1507